Description

Health Canada reviewed the potential risk of liver injury with Pradaxa after receiving reports of severe liver injury from the manufacturer. The manufacturer was asked to provide all available data on Pradaxa and the risk of liver injury.

Resources

Name	Format	Description	Link
Summary Safety Review - PRADAXA (dabigatran etexilate) - Assessing the potential risk of liver injury	HTML		https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/safety-reviews/pradaxa-assessing-potential-risk-liver-injury.html
Summary Safety Review - PRADAXA (dabigatran etexilate) - Assessing the potential risk of liver injury	HTML		https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medeffet-canada/examens-innocuite/pradaxa-evaluation-risque-potentiel-lesions-foie.html

Tags

Topics

Categories